Secondary breast angiosarcoma and paclitaxeldependent prolonged disease control: Report of two cases and review of the literature

Donatella Gambini, Roberto Visintin, Elisa Locatelli, Claudia Bareggi, Barbara Galassi, Letterio Runza, Concetta Blundo, Irina Sosnovskikh, Maurizio Tomirotti

Research output: Contribution to journalArticlepeer-review

Abstract

Secondary breast angiosarcomas are a well-known entity generally characterized by a poor outcome, especially in patients with advanced disease. Among the drugs with demonstrated activity, taxane derivatives are one of the most effective histology-driven treatments against angiosarcomas. We report two cases of secondary breast angiosarcoma, both characterized by a very peculiar behavior towards paclitaxel. Both patients showed local recurrence of angiosarcoma after primary surgery, and they achieved complete remission following treatment with weekly paclitaxel. When a locoregional recurrence was observed as a result of a brief treatment interruption or a treatment delay, a new complete remission was rapidly achieved with the resumption of the drug, without evidence of any significant adverse effects.

Original languageEnglish
Pages (from-to)e60-e63
JournalTumori
Volume101
Issue number2
DOIs
Publication statusPublished - Mar 1 2015

Keywords

  • Angiogenesis
  • Paclitaxel
  • Secondary breast angiosarcoma

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Medicine(all)

Fingerprint

Dive into the research topics of 'Secondary breast angiosarcoma and paclitaxeldependent prolonged disease control: Report of two cases and review of the literature'. Together they form a unique fingerprint.

Cite this